Skip to main content

Table 4 Univariable and multivariable Cox proportional hazards regression analysis for PFS and OS in the matched cohort

From: Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study

Variables

PFS

OS

Univariable

Multivariable

Univariable

Multivariable

Median PFS (mo)

P

HR (95% CI)

P

Median OS (mo)

P

HR (95% CI)

P

Sex

 

0.505

   

0.870

  

 Male

3

   

24

   

 Female

5

   

21

   

Age

 

0.275

   

0.239

  

 ≤60

4

   

24

   

 >60

3

   

25

   

Primary tumor site

 

0.054

1.59 (0.80, 3.18)

0.186

 

0.077

1.31 (0.62, 2.74)

0.480

 Colon

6

   

31

   

 Rectum

2

   

10

   

Grade

 

0.437

   

< 0.001

1.06 (0.13, 8.82)

0.959

 G1 and G2

5

   

62

   

 G3

3

   

10

   

Differentiation

 

0.048

1.68 (0.85, 3.33)

0.136

 

< 0.001

5.14 (0.68–38.79)

0.112

 NET

9

   

62

   

 NEC

2

   

9

   

Clinical T stage

 

0.656

   

0.589

  

 T1, T2

9

   

62

   

 T3, T4

4

   

24

   

Clinical N stage

 

0.873

   

0.263

  

 N0

5

   

62

   

 N1

4

   

24

   

Site of metastasis

 

0.735

   

0.130

  

 Single-organ

4

   

32

   

 Multiple-organ

4

   

18

   

PTR

 

0.613

   

0.983

  

 Yes

4

   

24

   

 No

4

   

31

   
  1. PFS: progression free survival, OS: overall survival, HR: hazards ratio, CI: confidence interval, NET: neuroendocrine tumor, NEC: neuroendocrine carcinoma, PTR: primary tumor resection